Flu Shot Injection - Search News

Agrees to review Moderna flu vaccine

FDA reverses course, will review Moderna's mRNA flu vaccine

Moderna said on Wednesday the U.S. Food and Drug Administration has agreed to review its influenza vaccine, reversing an earlier decision to reject the application, after the company made modification...

· 1d · on MSN

Moderna says FDA to review its flu vaccine after reversing course

· 1d · on MSN

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

· 1d

FDA reverses course on Moderna's flu vaccine

The FDA says it will now review a new m-r-n-a flu vaccine from Moderna.

· 1d

FDA reverses course and will review Moderna’s mRNA flu shot, company says

· 1d

FDA plans review of Moderna flu vaccine for older adults

· 1d

Moderna Jumps Above 20-Day Moving Average on FDA Flu Vaccine Review. Should You Buy MRNA Stock Here?

The FDA news is largely positive for MRNA stock as it positions the company’s influenza vaccine for the upcoming flu season.

· 1d

FDA reverses course, agrees to review Moderna's flu vaccine

· 1d

FDA Reverses Course and Will Now Review Moderna’s Flu Shot

1don MSN

Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) Feb 18 (Reuters) - A two-in-one mRNA vaccine developed by Moderna that targets seasonal influenza and COVID-19 produced robust and durable immune responses without safety concerns in a small mid-stage trial,

Scientists test universal vaccine for cold, flu, Covid and allergies

The nasal spray works to protect the lungs of mice, and could eventually replace multiple jabs if shown to be effective and safe for humans.